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Aim: Dementia patients are found to have more sleep disturbances that can affect their quality of life and
functional and cognitive abilities, and these disturbances are associated with greater risk of psychiatric
symptoms. The aim of this study is to investigate the presence of sleep disturbances among a group of
moderately patients with dementia and their effects on the development of depression, apathy, daytime
sleepiness, apathy, and caregiver stress.
Method: Baseline demographic data were collected in 105 participants with a mean age of 79 years. Sleep
disturbance was measured by Sleep Disorder Inventory (SDI). The Epworth Sleep scale (ESS) was used to
measure excessive daytime sleepiness, while the Cornell Depression score (CDS) was used to measure for
the presence of depressive symptoms. The Starkstein Apathy scale was used for assessment of apathy on
sleep and the Zarit Burden Interview (ZBI) was used to evaluate carer stress. We found that patients on
hypnotics generally have a higher SDI (4.7 vs, 1.48, p ¼ 0.021) and higher CDS (9.3 vs. 4.9, p ¼ 0.033).
There was no statistical signiﬁcant difference in different cholinesterase inhibitors on SDI, ESS, CDS,
apathy score, and carer stress. SDI was positively correlated with ESS, CDS, and ZBI, but not related to the
MMSE score and apathy. Linear regression found that ESS, CDS, and ZBI were independently associated
with SDI.
Conclusion: Sleep problems in dementia patients are associated with carer stress, excessive daytime
sleepiness, and depression using simple objective assessment instruments. This study helps to provide
insights into sleep disturbances in dementia patients and highlights the importance of this frequently
missed aspect in the care of dementia patients and their caregivers.
Copyright  2012, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
Sleep disturbances are common among older people, with 50%
of persons aged >65 years having reported at least one chronic
sleep problem.1 The ageing process cause changes in the typical
sleep pattern. Qualitative and quantitative alteration of sleep
related to aging has been well described. Changes of sleep quality
can lead to modiﬁcation in sleep architecture and will have
important inﬂuence on behavior and daytime activities.2 Quanti-
tative parameters, including a reduction of total sleep time due to
difﬁculties in falling asleep and frequent early morning wakening,
have been seen. It has been estimated that around 40% of patients
with Alzheimer disease have sleep disturbances.3 They have greater
sleep fragmentation and more frequent and longer periods of
intrasleep wakefulness. Although sleep disturbances were usuallyand Geriatrics, Kwong Wah
iu).
linical Gerontology & Geriatrics. Plinearly correlated with the severity of Alzheimer disease, certain
study4 suggested an inverted U-shaped proﬁle. Moderately
demented persons showmore impaired sleep than patients in early
and late disease stages.
Sleep disturbances such as insomnia and nighttime behaviors
are more common in persons with dementia than in cognitively
normal people.5 Sleep disturbances affect patient quality of life,
their functional and cognitive abilities,5 and are associated with
greater risk of development of psychiatric symptoms.6 All these
factors will pose greater burden on the caregiver, which can
contribute to their decision on institutionalization.7
Sleep disturbances represent a signiﬁcant clinical problem and
a major source of stress for caregivers.8 Longer sleep duration may
be an early sign of dementia and excessive daytime sleepiness has
been associated with twice the risk of incident dementia.9
Acetylcholine plays an active role in maintaining normal sleep
patterns, and is important for memory consolidation.10 For Alz-
heimer disease patients, taking cholinesterase inhibitors that
comply with the natural circadian ﬂuctuation of central cholinergic
transmission may be an important factor in clinical improvement.11ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Between group difference of dementia types and SDI, depressive symptoms,
daytime sleepiness, apathy, and carer stress.
Alzheimer’s
disease
(N ¼ 56)
Vascular
dementia
(N ¼ 5)
Parkinson’s
disease
dementia (N ¼ 5)
Mixed
dementia
(N ¼ 33)
p value
MMSE (SD) 17.75 (4.7) 22.2 (5.4) 12.4 (4.7) 18.33 (4.8) 0.009
SDI 1.67 (2.5) 0.40 (0.4) 5.6 (6.7) 1.93 (2.8) 0.038
ESS 8.25 (6.6) 10.0 (6) 11.8 (5.8) 11.45 (7.3) 0.236
CDS 5.29 (5.8) 5.4 (5.6) 5.2 (3.6) 5.73 (5.2) 0.93
Apathy 20.7 (7.6) 22.2 (4) 24 (0) 22.97 (5.3) 0.531
ZBI 27.3 (16.7) 25.6 (15.8) 46.4 (26.3) 29.58 (18.2) 0.226
Apathy scale: Starkstein apathy scale.
CDS ¼ Cornell depression scale; ESS ¼ Espworth sleepiness scale; MMSE ¼ mini-
mental state examination; SDI ¼ Sleep disorder inventory; ZBI ¼ Zarit Burden
Interview.
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of sleep disturbances in investigate the inﬂuence of sleep distur-
bances on carer stress. The third objective is to assess the effect of
different cholinesterase inhibitors on sleep hygiene.
2. Methods
Patients attending the memory clinic of a regional hospital were
recruited. Inclusion criteria were Mini-Mental State Examination
(MMSE) score >10, and having a bed partner who was the care-
giver. Those with acute delirium or confusion or previous psychotic
disorders were excluded. Basic demographic data, drug history, and
types of cholinesterase inhibitor were recorded.
Types of dementia were classiﬁed accordingly to diagnostic and
statistical manual of mental disorder (DSM-IV) criteria. Duration of
cholinesterase inhibitors therapy were calculated from the date of
starting drugs treatment to the date of assessment of sleep distur-
bances. Those on combination therapy with cholinesterase inhibi-
tors and memantine were excluded to avoid confounding effect on
individual types of cholinesterase inhibitor. Doses of cholinesterase
inhibitors were titrated up to patients’ tolerance. Concomitant
drugs that have effect on sleep were recorded according to a list of
common medications related to sleep disturbances.12
Sleep Disorder Inventory (SDI)3 was used for assessment and
quantifying sleep disturbance. It consists of seven subquestions
from the Neuropsychiatric inventory (NPI) sleep disturbance item.
Each of the subquestions was made into a separate question with
frequency, severity, and caregiver distress rated by caregiver with
respect to the patient. SDI score is calculated by the product of the
average of the frequency and severity score of the seven separate
sleep disturbance symptoms. The higher the score, the more severe
the sleep disturbance. Caregiver distress ratings are not part of the
SDI total score. The Epworth Sleep scale (ESS)13 was administered to
caregivers for assessment of day time sleepiness. It provided
a caregiver estimate of patient sleepiness in eight everyday situa-
tions. A score of>10was considered indicative of excessive daytime
sleepiness. The Cornell Depression scale (CDS)14 was used to assess
for the presence of depressive symptoms in dementia participants.
A higher score means greater depressive symptoms. The Starkstein
Apathy scale15 was used to study spontaneity, initiation, emotion-
ality, activity level, and interest in hobbies. This scale was used in
a self-assessment. An answer to each question was scored in four
grades, 0 to 3, and the total score was used for the analysis. Carer
stress was measured by the Chinese version of the Zarit Burden
Interview.16 It is speciﬁcally designed to assess the subjective
burdenof carers, deﬁned as the extent towhich carers perceive their
emotional or physical health, social life, and ﬁnancial status have
changed as a result of caring for their relatives with dementia. The
higher the score, the greater the carer stress. Written consent was
obtained from the participants and their caregivers. Approval from
the Hospital Authority Regional ethical committee was obtained.
2.1. Statistical method
Descriptive statistics using student t-test for continuous data
and chi-square test for categorical data wherever appropriate. One-
way analysis of variance (ANOVA) and post hoc tests were used to
assess the difference among different types of dementia on sleep
disturbances, ESS, CDS, apathy score, and care stress. Correlation
coefﬁcients were calculated between the SDI scores and MMSE,
CDS, ESS, Starkstein Apathy scale, and Zarit Burden Interview.
Different types of cholinesterase inhibitors on sleep disturbance,
ESS, CDS, apathy, and carer stress were analyzed by ANOVA with
adjustment for treatment duration. A p value of <0.05 was
considered signiﬁcant.3. Results
A total of 105 participants met our inclusion criteria. The mean
age was 78.9 years (standard deviation, SD 10.35). A total of 70
(66.7%)werewomen. 49 (46.7%)were livingwith their spouse as the
major carer, 46 (43.8%) were living with their children. Eight (7.6%)
were cared by amaid. ThemeanMMSEwas 18 (SD 5) with a median
duration of illness since diagnosis of 2 years. The mean SDI was 1.85
(SD 2.9), ESS was 9.35 (SD 6.9), CDS 5.43 (SD 5.4), apathy score was
21.5 (SD 6.7), and ZBI was 28.9 (SD 17.8). More than one-half of our
participants had Alzheimer dementia (AD); 59, (56.2%), 34 (32.4%)
had mixed dementia, six (5.7%) had vascular dementia, and ﬁve
(4.8%) had Parkinson disease dementia (PDD). A total of 84 (80%) of
them were taking cholinesterase inhibitors. Among them, 42 (50%)
were on donepezil, 24 (28.5%) were on rivastigmine, 13 (5.5%) were
on galantamine, and two (2.4%) were on memantine. Three of them
(3.6%) were on both cholinesterase inhibitors and memantine. Only
13 (12.4%) of participants were prescribed with a hypnotic medica-
tion for sleep problems. A total of 57 (54.8%) of our participants
received drugs that affect sleep. There was no signiﬁcant difference
between use of these drugs on SDI, MMSE, CDS, ZBI, and apathy
scores. About one-half of our participants (46) were considered to
have excessive daytime sleepinesswith anESS>10. Therewasno sex
difference on SDI, CDS, apathy scale, and carer stress. However,
female sex was found to have a lower MMSE [17 vs. 20, 95% conﬁ-
dence interval (CI) 0.84e4.72, p ¼ 0.006] and lower ESS (8.3 vs. 11.3,
95% CI 0.39e5.6, p ¼ 0.025). There was signiﬁcant between group
difference in MMSE among the dementia types (F ¼ 3.67, df ¼ 3,
p ¼ 0.015). Post hoc tests showed that PDD signiﬁcantly lowered
MMSE scores when compared with other types of dementia. Simi-
larly, therewas also signiﬁcant difference in SDI among thedementia
groups (F ¼ 3.37, df ¼ 3, p ¼ 0.022) and post hoc tests also showed
that PDD had a signiﬁcantly higher SDI score. However, therewas no
statistically signiﬁcant difference among dementia types on ESS,
CDS, apathy score, and carer stress (Table 1). There was statistically
signiﬁcant difference between duration of drug therapy of different
types of cholinesterase inhibitor (Table 2). There was no statistically
signiﬁcant difference on the different types of cholinesterase inhib-
itor on SDI, ESS, CDS, apathy score, and carer stress after adjustment
for duration of cholinesterase inhibitors therapy (Table 2).
We found that participants prescribed with hypnotic medica-
tions have a higher SDI (4.77 vs. 1.48, 95% CI 0.59e6, p ¼ 0.021) and
CDS (9.3 vs. 4.9, 95% CI 0.41e8.43, p ¼ 0.033). There was no
difference among participants taking hypnotics with respect to ESS,
apathy score, and carer stress.
The clinical correlates of sleep disorder were associated with
daytime sleepiness, depressive symptoms and carer stress
(Table 3), whereas global cognition MMSE and apathy score did not
differ. Linear regression showed that ESS (beta 0.18, p¼ 0.036), CDS
Table 2
Relationship between types of cholinesterase inhibitors and sleep and nonsleep
variables.
Donazepil
(N ¼ 40)
Rivastigmine
(N ¼ 23)
Galantamine
(N ¼ 13)
Memantine
(N ¼ 2)
p
value
Duration
of therapy
(days/SD)
745.5 (483.1) 372.2 (336.6) 480.2 (492.9) 716 (280) <.001
SDI 1.75 (2.9) 2.21 (3.2) 1.3 (1.6) 0.98 (1.4) 0.75
ESS 8.33 (7) 12.09 (7.5) 7.55 (4.8) 0.5 (0.7) 0.073
CDS 4.4 (5.4) 6.61 (4.6) 4.64 (4.8) 3 (4.2) 0.518
Apathy 21.88 (7.3) 22 (7.5) 21.27 (5.2) 13 (2.8) 0.512
ZBI 23.7 (13.1) 29.74 (18.6) 34.82 (24.1) 34 (9.9) 0.279
Apathy scale: Starkstein apathy scale.
CDS ¼ Cornell depression scale; ESS ¼ Epworth Sleep scale; SDI ¼ sleep disorder
inventory; ZBI ¼ Zarit Burden Interview.
Table 4
Presence of excessive daytime sleepiness with SDI, depressive symptoms, and carer
stress.
ESS <10 ESS >10 95% CI p value
SDI 3.2 8.1 1.25, 3.5 <0.001
CDS 4 7.3 1.24, 5.28 <0.001
ZBI 23.4 35.8 5.47, 19.46 0.001
CDS¼ Cornell depression scale; CI¼ conﬁdence interval; ESS¼ Epworth Sleep scale;
SDI ¼ sleep disorder inventory; ZBI ¼ Zarit Burden interview.
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pendent predictors for SDI.
CDS is positively correlated with SDI, ESS and apathy score
(r ¼ 0.53, 0.37, 0.25 respectively; p < 0.001). After adjustment for
the effect of sleep disturbances, CDS is still positively correlated
with apathy (r ¼ 0.22, p ¼ 0.026).
When we deﬁned presence of excessive daytime sleepiness as
ESS>10, participants who experience excessive daytime sleepiness
have more sleep disturbance, experience more depressive symp-
toms and have higher carer stress (Table 4).
4. Discussion
This study examined the presence of sleep disturbance among
mild to moderate dementia participants and its relationship to
carer stress and depressive symptoms. Most of our participants
reported some degree of sleep disturbance. Only a few of them (16,
15.2%) had no complaints on sleep, with an SDI of 0. Sleep problems
were more common in participants with PDD. Little is known
regarding the possible underlying mechanisms causing sleep
problems in dementia patients. It is likely that different factors can
contribute to their development. Environmental, genetic, and
disease related factors can explain all or part of it. A different
pattern of sleep disorder was found in AD compared with dementia
with Lewy bodies (DLB), where probable rapid eye movement
(REM) sleep behavior disorder (RBD) and excessive daytime
sleepiness were common. It supports the hypothesis that a certain
proportion of the sleep disorders in these two diseases are asso-
ciated with different underlying brain mechanisms of each disease.
RBD is frequent in the a-synucleinopathies, Parkinson disease, PDD,
and DLB are less common in the non a-synucleinopathies, sug-
gesting that the neurodegeneration differentially affects the neural
networks involved in RBD pathophysiology especially those in the
pons and medulla.17
It has been reported that the hypocretin-1 system18 affects the
regulation of the ﬂip-ﬂop switch for REM sleep and wakefulness. A
low level of hypocretin-1 in the brain results in clinical feature and
characteristics of narcolepsy such as fragmented sleep continuity,Table 3
Nonparametric correlations: SDI and nonsleep variables.
Clinical correlates SDI p value
MMSE -0.028 0.78
ESS 0.408 <0.001
CDS 0.531 <0.001
Apathy scale 0.131 0.182
ZBI 0.46 <0.001
Apathy scale: Starkstein apathy scale.
CDS ¼ Cornell depression scale; ESS ¼ Epworth Sleep scale; MMSE ¼ Mini-Mental
State Examination; SDI ¼ sleep disorder inventory; ZBI ¼ Zarit Burden interview.hypnopompic, and hypnagogic hallucinations, sleep paralysis and
cataplexy. Recent study19 showed that hypocretinergic cell loss in
the lateral hypothalamus in patients with Parkinson disease could
contribute to the narcoleptic like features of Parkinson disease, PDD
and DLB. However, a study by Compta20 found that cerebralspinal
ﬂuid (CSF) hypocretin-1 levels are normal and unrelated to severity
of sleepiness or the cognitive status in PDD patients. There is
a differential degree of degeneration that could explain the
different frequencies of several sleep problems in patients with AD
and DLB. In addition to the hypocretin system, different changes in
serotonergic, dopaminergic and cholinergic neurotransmitter
systems may contribute to the different patterns of sleep distur-
bances in AD and DLB.17 This can explain why our PDD patients
have a higher SDI than in other types of dementia.
Our study did not show any gender difference in sleep problems.
Volderholzer21 showed that both objective (polysomnography-
based) and subjective reports of sleep disturbances were not
associated with respondent sex. Study22 of sleep and circadian
rhythms in older adults and those with dementia have only
inconsistently shown gender difference in daytime sleepiness,
insomnia, and circadian phase.
Total SDI score was not associated with patient sex or dementia
duration, but it was cross-sectionally associated with carer stress,
depressive symptoms, and excessive daytime sleepiness. Interest-
ingly, SDI score was not associated with worse dementia in this
cohort. This is in contrast with the study by Moe,23 which was
based on REM, not actigraphic, objective sleep data. We suggest
that it may be the characteristic of our patient group that the mean
MMSE was already in the moderate to near severe dementia range.
It may not be sensitive enough to showany signiﬁcant difference on
dementia severity with SDI.
Caregivers were distressed by the nighttime behavior of the
participants as indicated by a positive correlation between ZBI and
SDI, ESS, and CDS. Excessive daytime sleepiness deﬁned as ESS >10
was reported by 46 (43.8%) of our respondents. This is not an
uncommon phenomenon. Caregiver distress was much greater
among those who have excessive daytime sleepiness. This would
likely be true for most caregivers. Caregivers must be aware that
maintaining proper sleep hygiene and not napping during the day24
might decrease sleep disturbance, while typical caregivers might
value a respite provided by daytime sleeping of their patients. It
means that caregivers are not aware that they may be trading their
own nighttime sleep for this daytime break.
We found no correlation between MMSE and ESS (r ¼ 0.089,
p ¼ 0.367). This is in contrast with studies25,26 that showed that
excessive daytime sleepiness was signiﬁcantly related to dementia
and that the degree of sleepiness varies together with the extent of
the disease. However, our results are similar to the ﬁndings by
Bliwise27 that the relationship between sleepiness and severity of
the disease might account for the absence of daytime sleepiness
documented in a sample of AD patients with a higher mean MMSE
score (24.9 SD 2.9) than that of our study population. Although the
majority of our participants (>85%) reported some degree of sleep
disturbance, these complaints were not associated with severity of
cognitive impairment. Actually, symptoms of poor sleep were
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demented ones. This result is not surprising since several studies
have already shown that insomnia symptoms are not related to
cognitive impairment in older adults.28 The diagnosis of insomnia
becomes more difﬁcult with increasing cognitive decline. A diag-
nosis of insomnia in demented participants relies on a caregiver’s
report. Theymight not be able to recognize this clinical condition in
a particular situation. For instance, the duration of a patient in bed
at night with eyes open is not considered insomnia if the caregiver
remains asleep. Moreover, insomnia could be masked by the
regular administration of hypnotic/sedative drugs in patients who
have severe cognitive impairment.
The ZBI indicates that the problem of sleep disturbance in
dementia participants is a signiﬁcant cause of distress. The low
incidence of prescription of nighttime medications may represent
the reluctance of people caring for these elderly patients with
dementia to prescribe addictive benzodiazepines or other poten-
tially dangerous neuroleptics, a lack of enquiry on the part of the
treating doctor, or previous ineffective treatment with hypnotic
medications. It has been shown that29 the typical change in sleep
proﬁle in AD and DLB is characterized by a loss of REM sleep and, as
most benzodiazepines and sedating antidepressants are REM
suppressors, they may contribute to a paradoxical effect on sleep
architecture. Suggestions should be made to physicians taking care
of these groups of dementia patients to improve sleeping patterns
either by drugs therapy or behavioral therapy. A signiﬁcant
reduction of carer stress is expected with improvement in sleep
disturbances among the patients and this may translate to better
quality of life of both patients and their carers and help reduce the
incidence of institutionalization.
Sleep disturbance is positively correlated with depressive
symptoms. As a demented person sleeps poorly, there will be
a negative effect on their self-rated health and mood and depres-
sive symptoms arise. This may translate to apathy. This is supported
by our ﬁnding that CDS is positively correlated with apathy even
after adjustment for sleep disturbance. This ﬁnding suggests that,
once depression occurs in dementia patients, they tend to have
a lower threshold for apathy and that there may be an interaction
between depression and the dementing process. It was suggested
that15 apathetic AD patients (with or without depression) also had
signiﬁcantly more severe extrapyramidal signs than non-apathetic
AD patients, suggesting that apathy may account for some of the
functional impairment in AD patients. The complex interaction of
sleep disturbance, depression, and apathy all contribute to a dis-
tressing condition for both patients and their caregivers.
Our study did not ﬁnd any signiﬁcant differences among the
different types of cholinesterase inhibitors on sleep disturbance,
depressive symptoms and apathy. This is in contradiction to an
earlier report29 that patients who were started on rivastigmine
showed a reduction in the level of sleep disturbance and a reduc-
tion in carer stress. Rivastigmine also reduced daytime sleepiness,
as reﬂected by a fall in the ESS. The cholinergic system plays an
important part in the control of arousal. We suggest that perhaps
the small number of participants on rivastigmine was not adequate
enough to show any signiﬁcant difference. If a larger trial can show
an improvement in sleep proﬁle with the prescription of cholin-
esterase inhibitors for the treatment of cognitive impairment or
non-cognitive symptoms of dementia, then the need for potentially
more dangerous drugs such as benzodiazepines and neuroleptics
can be reduced.
There are several limitations in this study. Use of SDI is based on
a caregiver’s report. There may be a discrepancy between
a patient’s own complaint of sleep problem and a caregiver report.
Caregivers may not report sleep problems unless their own sleep is
disturbed. Discrepancies do exist between what the caregiversuggests for the sleep problem in the patient and what the patient
reports himself. Patients whowere less cognitively and functionally
impaired and less depressed with better self-rated quality of life
tended to sleep well despite caregivers reporting the contrary.
Caregivers who tended to use criticism as a behavioral manage-
ment strategy were more likely to make discrepant reports about
the patients’sleep.30 Interpretation of our data is limited by the
modest size of the study population and the lack of follow up. Cause
and effect relationship among sleep disturbances and patients’
characteristics cannot be assessed in this cross sectional design.
We do not have a standardized assessment of all of the different
types of sleep disorders. A standardized assessment by experts in
sleep medicine using established criteria for key sleep disorders
and polysomnography with or without multiple sleep latency tests
is the optimal way to evaluate frequency, type, severity, and effect
of sleep disturbances on patients and their carers. However, the SDI
questionnaire used in this study is a simple and short instrument
that can be administered once to characterize the period before an
evaluation, and can be administered at a screening or ﬁrst evalua-
tion visit. Conversely, sleep diaries, polysomnography, and wrist
actigraphy need sophisticated preparation and restrict the inclu-
sion of too many participants, especially in an outpatient setting.
The use of these objective measurement instruments is also
restricted by resources constraints and inconvenience to both
patients and their carers. Moreover, compliance with poly-
somnography in patients with dementia is questionable.5. Conclusion
Sleep problems in dementia patients are associated with carer
stress, excessive daytime sleepiness, and depression using simple
objective assessment instruments. For better whole-patient care, it
is better to include an assessment of caregiver’s sleep so as to
provide a general idea of the extent to which their sleep was
disturbed and the quality of life of both patients and their care-
givers. The information provided in this study helps provide
insights into the importance of sleep disturbance in dementia
patients and highlights the importance of this frequently missed
aspect in the care of dementia patients and their caregivers.
Research should focus on treatment and outcomes such as quality
of life, medical comorbidity, and mortality in dementia patients
with sleep disturbances.References
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